Pnc Financial Services Group, Inc. Nurix Therapeutics, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $162 Billion
- Q3 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 440 shares of NRIX stock, worth $5,416. This represents 0.0% of its overall portfolio holdings.
Number of Shares
440
Previous 130
238.46%
Holding current value
$5,416
Previous $1,000
300.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding NRIX
# of Institutions
174Shares Held
79.5MCall Options Held
126KPut Options Held
11.3K-
Black Rock Inc. New York, NY6.82MShares$84 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.06MShares$74.7 Million2.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.49MShares$55.3 Million0.0% of portfolio
-
Commodore Capital LP New York, NY3.95MShares$48.6 Million4.19% of portfolio
-
Baker Bros. Advisors LP New York, NY3.88MShares$47.8 Million0.45% of portfolio
About Nurix Therapeutics, Inc.
- Ticker NRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,147,800
- Market Cap $580M
- Description
- Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...